We examined the absorption of phenolsulfonphthalein (PSP) and fluorescein isothiocyanate dextrans MW 4,400; MW 9,500; MW 40,500) as model compounds through the small intestinal serosal surface. After application to the rat small intestinal serosal surface using a cylindrical diffusion cell, each compound was absorbed at different rates. The absorption ratios in 6 h after PSP, FD-4, FD-10 and FD-40 application were calculated to be 89.2, 34.6, 14.9 and 2.1 % of dose, respectively. Elimination profiles of PSP, FD-4 and FD-10 from the small intestinal serosal surface obeyed firstorder kinetics. Moreover, we calculated the apparent permeability coefficient P app for comparison to other organ surfaces. The kidney had the highest absorption efficiency, as shown by having more than 1.5 times significantly higher P app values of PSP, FD-4 and FD-10. Similar to the other organ surfaces, a correlation was observed between the P app of small intestine and the molecular weight of these hydrophilic compounds. In addition, the small intestine is likely to contribute largely to hydrophilic compounds absorption from the peritoneal cavity, judging from absorption clearance CL a calculated by utilizing the peritoneal organ surface area.
Introduction
The peritoneal cavity is a useful space for intraperitoneal (i.p.) chemotherapy of cancer restricted to the peritoneal cavity, such as peritoneal carcinomatosis and ovarian cancer.
The clarification of drug absorption characteristics from the peritoneal cavity would improve peritoneal chemotherapy.
Intraperitoneally administered drugs are possibly absorbed from the peritoneum surrounding these peritoneal organs and the abdominal wall. Previously, we reported on drug absorption from the liver surface (Nishida et al 1994) , kidney surface (Nishida et al 2004) , serosal stomach surface (Mukai et al 1999; Nakamura et al 1999) and serosal caecal surface (Nishida et al 2002) in rats utilizing the diffusion cell, and demonstrated the possibility that the peritoneal organ surface was greatly responsible for drug absorption from the peritoneal cavity. Because the small intestine has the largest peritoneal area (Flessner 1996) , its contribution to drug absorption from the peritoneal cavity might be considerable.
In this study, we have examined the absorption of model compounds with different molecular weights after their application to the rat small intestinal serosal surface, by utilizing a diffusion cell. Phenolsulfonphthalein (PSP) and fluorescein isothiocyanate dextrans (FDs) were selected as model compounds because their absorption characteristics from other organ surfaces have been studied (Nishida et al 1995, buffer (pH 7.4) to yield a concentration of 30 mg mL -1 and were administered as follows:
A cylindrical diffusion cell (i.d. 4 mm, area 0.13 cm 2 ) was attached to the rat small intestinal serosal surface with the biocompatible glue Aron Alpha (Sankyo Co. Ltd, Tokyo, Japan).
The drug solution (1 mg in 0.0334 mL) was added directly into the diffusion cell. The top of the diffusion cell was sealed with aluminum foil to prevent evaporation.
Blood samples (200 μL) were collected at selected times after dosing from the heparinized cannula inserted into the femoral artery over a 6 h period, and were centrifuged at 15,000 rpm for 5 min. Bile samples were collected at appropriate time intervals for 6 h. At 6 h after the application, urine was collected directly from the bladder with a syringe, and the drug solution remaining in the diffusion cell was withdrawn. Certain experiments were carried out up to 0.5, 1, 2, 4 and 6 h after drug application.
Analysis
The concentrations of free PSP in the plasma, bile, urine and the solution remaining in the diffusion cell were determined spectrophotometrically at 560 nm after dilution with 1 M NaOH solution, by modifying the method previously described (Hart and Schanker 1966) . The total concentrations of free PSP and its metabolite were similarly measured after acid hydrolysis 
Statistical Analysis
In all cases, post-hoc comparisons of the means of individual groups were performed using Tukey's test, following a one-way ANOVA. A significance level of P < 0.05 denoted significance in all cases. All values were expressed as the mean value ± standard error (SE) of at least independent different four experiments.
Results
Possibility of drug absorption from the rat small intestinal serosal surface Figure 1 shows the plasma concentration profiles of PSP, FD-4
and FD-10 after application to the rat small intestinal serosal surface at a dose of 1 mg using the diffusion cell.
After absorption from the small intestinal serosal surface, each model compound appeared in the plasma. FD-4 and FD-10 appeared in the plasma at significantly lower concentrations than PSP at each time point (Fig. 1 ). Table 1 lists the recovery of model compounds in the diffusion cell, bile and urine 6 h after application to the small intestinal serosal surface at a dose of 1 mg. The absorption ratio (% of dose) in 6 h of model compounds from the small intestinal serosal surface was calculated from the amount recovered from the diffusion cell at 6 h after application.
Recovery of model compounds in the diffusion cell, bile and urine
The absorption ratio of PSP (89.2 %) was significantly larger than FD-4 (34.6 %), FD-10 (14.9 %) and FD-40 (2.1 %).
After application to the small intestinal serosal surface, model compounds were excreted into the bile and urine as listed in Table 1 
Discussion
Because the small intestine occupies about 40 % of the total peritoneal area in rats (Flessner 1996), we considered that its contribution to drug absorption from the peritoneal cavity was remarkable. Flessner reported that absorption from the peritoneal cavity was dependent on the surface area exposed to the solution (Flessner 1996) . To obtain information about drug absorption characteristics after i.p. administration, as a first step, we compared the drug absorption rates from several organ surfaces such as the liver (Nishida et al 1996) , kidney (Nishida et al 2004) , stomach (Mukai et al 1999) and caecum (Nishida et al 2002) ), by employing the apparent permeability coefficient P app . P app was calculated as the absorption clearance per application area, according to the following equation:
Where V a is the application volume of the drug solution, and A cell is the application area of the diffusion cell. Table 2 summarizes the P app of PSP, FD-4 and FD-10 after application to several organ surfaces. The P app values of PSP, FD-4 and FD-10 were not significantly changed for small intestine, liver, stomach and caecum. While the kidney had the largest P app values of PSP, FD-4 and FD-10, as shown by a more than 1.5 times significantly higher P app value compared to other organ surfaces. These results suggest that the kidney has the highest absorption efficiency for various molecular weight compounds among these organ surfaces.
Flessner measured the mass transfer rates of mannitol to the plasma from fluid in diffusion chambers affixed to the peritoneal surfaces of the rat caecum, liver, stomach and abdominal wall, and determined that the rates of mannitol transport were similar for all four organs (Flessner 1996) .
The present result is in agreement with this previous study by
Flessner (Flessner 1996) on the similar P app of the rat caecum, liver and stomach. However, we additionally indicated higher P app for kidney surface of several model compounds with different molecular weights.
We have clarified that the absorption rates from several organ surfaces were dependent on the molecular weights of the model compounds (Nishida et al 1996 (Nishida et al , 2002 (Nishida et al , 2004 Mukai et al 1999) . Then, we compared the absorption rates of model for the small intestinal serosal surface, similar to liver (Nishida et al 1996) , kidney (Nishida et al 2004) , stomach (Mukai et al 1999) and caecum (Nishida et al 2002) . This suggests that these hydrophilic model compounds were absorbed from the rat small intestinal serosal surfaces membranes via simple passive diffusion by the paracellular pathway, similar to other organ surfaces. Table 2 lists the molecular weights when the P app values are 0 (MW limit), calculated by using the intercept of the x-axis (P app = 0) on the relationship between the P app and 1/ MW . We considered that these values are equivalent to the limits of the molecular weights of drugs which can be absorbed from each organ surface in rats. The limits of the molecular weights were different among the organ surfaces.
Furthermore, we calculated absorption clearance (CL a ), according to Eq. 3, to estimate the contribution ratio for each organ to absorption from the peritoneal cavity.
CL a is the absorption clearance on the peritoneal organ itself from the peritoneal cavity. A organ is the peritoneal surface area of an organ, which was previously measured (Flessner 1991) . In this case, we assumed that each organ would contribute to drug absorption from the peritoneal cavity according to its proportion of peritoneal surface area in contact with the peritoneal fluid. As listed in Table 2, CL a values for the small intestine with every model compound were the significantly highest among these organ surfaces, probably by virtue of having the largest peritoneal area in the peritoneal cavity. These results suggest that absorption from the small intestinal serosal surface contributes the most to hydrophilic drug absorption from the peritoneal cavity.
In conclusion, we clarified the absorption characteristics of model compounds with different molecular weights from the rat small intestinal serosal surface by the paracellular pathway. These results should be useful to estimate overall hydrophilic drug absorption rates after i.p. administrations. Each value is the mean ± s.e. of at least four experiments.
a) The biliary and urinary recoveries of PSP represent the total amount of free PSP and its metabolite. b) FD-40 could not be detected in the bile and urine. Each value is the mean ± s.e. of at least four experiments. The number of the experiments were indicated in the parenthesis. a) P app was calculated by using k a according to equation 1. k a values were obtained previously: liver (Nishida et al 1995 (Nishida et al , 1996 , kidney (Nishida et al 2004) , stomach (Mukai et al 1999) , and caecum (Nishida et al 2002) Each point represents the mean ± s.e. of four experiments.
When no error bar is given, s.e. is smaller than the symbol used.
